Monogenic severe insulin resistance syndromes;Syndromes d'insulinorésistance extrême géné tiquement déterminés

Revue de Medecine Interne

Volumn 26, Issue 11, 2005, Pages 866-873

  Vincent Desplanques, D ^a   Faivre Defrance, F ^a   Wemeau J L ^a   Vantyghem, M C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dunnigan; Insulin receptor; Insulin resistance; Lamin; Lipodystrophy

Indexed keywords

INSULIN; LAMIN A; LAMIN C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

CLINICAL FEATURE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INSULIN RESISTANCE; JAW MALFORMATION; LIPOATROPHIC DIABETES MELLITUS; METABOLIC SYNDROME X; MUTATOR GENE; RECEPTOR GENE; REVIEW; TYPE A BEHAVIOR;

EID: 27844543299     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.04.027     Document Type: Short Survey

References (37)

1. R.S. Yalow, and S.A. Berson Dynamics of insulin secretion in early diabetes in humans Adv. Metab. Disord. 1 supl 1 1970 95 100
2. A. Boulogne, and M.C. Vantyghem Études ́pid́ miologiques et crit̀res diagnostiques du syndrome ḿtabolique; physiopathologie de l'insulinoŕsistance; principes de traitement Presse Med. 33 2004 666 681
3. D.E. Moller, and J.S. Flier Insulin resistance-mechanisms, syndromes, and implications N. Engl. J. Med. 325 1991 938 948
4. S.I. Taylor, A. Cama, D. Accili, F. Barbetti, E. Imano, and H. Kadowaki Genetic basis of endocrine disease 1: molecular genetics of insulin resistant diabetes mellitus J. Clin. Endocrinol. Metab. 73 1991 1158 1163
5. R.N. Kulkarni, J.C. Bruning, J.N. Winnay, C. Postic, M.A. Magnuson, and C.R. Kahn Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes Cell 96 1999 329 339
6. N. Longo, Y. Wang, S.A. Smith, S.D. Langley, L.A. Di Meglio, and D. Giannella-Neto Genotype-phenotype correlation in inherited severe insulin resistance Hum. Mol. Genet. 11 2002 1465 1475
7. R.B. Paisey, C.M. Carey, L. Bower, J. Marshall, P. Taylor, and P. Maffey Hypertriglyceridemia in Alström's syndrome: causes and associations in 37 cases Clin. Endocrinol. 60 2004 228 231
8. J. Capeau, J. Magre, C. Reynet, G. Cherqui, M. Caron, and B. Melin Les ŕcepteurs de l'insuline Ann. Med. Int. 141 1990 145 155
9. T. Kitamura, Y. Kitamura, J. Nakae, A. Giordano, S. Cinti, and C.R. Kahn Mosaic analysis of insulin receptor function J. Clin. Invest. 113 2004 209 219
10. J. Girard Rôle des acides gras libres dans la ścŕtion et l'action de l'insuline dans les ḿcanismes de lipotoxicit́ Med. Sci. (Paris) 19 2003 827 833
11. R. Rabasa-Lhoret Laville M Mesurer l'insulinosensibilit́ en pratique clinique Diab. Metab. 27 2001 201 208
12. C.R. Kahn, J.S. Flier, R.S. Bar, J.A. Archer, P. Gorden, and M. Martin The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man N. Engl. J. Med. 294 1976 739 745
13. D.E. Moller, O. Cohen, Y. Yamaguchi, R. Assiz, F. Grigorescu, and A. Eberle Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance Diab. 43 1994 247 255
14. S.I. Taylor, D. Accili, A. Cama, H. Kadowaki, T. Kadowaki, and E. Imano Unusual forms of insulin resistance Annu. Rev. Med. 42 1991 373 379
15. S.M. Rabson, and E.N. Mendenhall Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus Am. J. Clin. Path. 26 1956 283 290
16. C. Musso, E. Cochran, S.A. Moran, M.C. Skarulis, E.A. Oral, and S. Taylor Clinical course of genetic diseases of the insulin receptor (type A and Rabson Mendenhall syndromes): a 30-year prospective Med. 83 2004 209 222
17. A. Krook, L. Brueton, and S. O'Rahilly Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism Lancet 342 1993 277 278
18. E. Wertheimer, S.-P. Lu, P.F. Backeljauw, M.L. Davenport, and S.I. Taylor Homozygous deletion of the human insulin receptor gene results in leprechaunism Nat. Genet. 5 1993 71 73
19. A. Garg Acquired and inherited lipodystrophies N. Engl. J. Med. 350 2004 1220 1234
20. W. Berardinelli An undiagnosed endocrinometabolic syndrome: report of two cases J. Clin. Endocr. 14 1954 193 204
21. M. Seip, and O. Trygstad Generalized lipodystrophy Arch. Dis. Child. 38 1963 447 453
22. J. Magŕ, M. Deĺpine, E. Khallouf, T. Gedde-Dahl Jr., L. Van Maldergem, and E. Sobel Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13 Nat. Genet. 28 2001 365 370
23. A.K. Agarwal, E. Arioglu, S. De Almeida, N. Akkoc, S.I. Taylor, and A.M. Bowcock AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 Nat. Genet. 31 2002 21 23
24. R.D. Lawrence Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances: a case throwing new light on the action of insulin Lancet I 1946 724 731 [and 773-775]
25. M.C. Vantyghem, P. Pigny, C.A. Maurage, N. Rouaix-Emery, T. Stojkovic, and J.M. Cuisset Patients with familial lipodystrophy of the Dunningan type due to a LMNA R482W mutation show muscular and cardiac abnormalities J. Clin. Endocrinol. Metab. 89 2004 5337 5346
26. S. Shackleton, D.J. Lloyd, S.N. Jackson, R. Evans, M.F. Niermeijer, and B.M. Singh LMNA, encoding lamin A/C, is mutated in partial lipodystrophy Nat. Genet. 24 2000 153 156
27. C. Vigouroux, J. Magŕ, M.C. Vantyghem, C. Bourut, O. Lascols, and S. Shackleton Sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy Diab. 49 2000 1958 1962
28. V. Simha, and A. Garg Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia J. Clin. Endocrinol. Metab. 87 2002 776 785
29. G. Novelli, A. Muchir, F. Sangiuolo, A. Helbling-Leclerc, M.R. D'Apice, and C. Massart Mandibuloacral dysplasia is caused by a mutation in LMNA gene encoding lamin A/C Am. J. Hum. Genet. 71 2002 426 431
30. V. Simha, A.K. Agarwal, E.A. Oral, J.-P. Fryns, and A. Garg Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy J. Clin. Endocrinol. Metab. 88 2003 2821 2824
31. J. Kobberling, and M.G. Dunnigan Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state J. Med. Genet. 23 1986 120 127
32. K.L. Herbst, L.R. Tannock, S.S. Deeb, J.Q. Purnell, J.D. Brunzell, and A. Chait Köbberling type of familial partial lipodystrophy: an underrecognized syndrome Diab. Care 26 2003 1819 1824
33. A.K. Agarwal, and A. Garg A novel heterozygous mutation in peroxisome proliferator activated receptor-gamma gene in a patient with familial partial lipodystrophy J. Clin. Endocrinol. Metab. 87 2002 408 411
34. R.A. Hegele, H. Cao, C. Frankowski, S.T. Mathews, and T. Leff PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy Diab. 51 2002 3586 3590
35. I. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, and J.L. Goldstein Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nat. 401 1999 73 76
36. E. Cochran, J.R. Young, N. Sebring, A. Paoli, E.A. Oral, and P. Gorden Efficacy of recombinant methionyl human leptin therapy fdor the extreme insulin resistance of the Rabson Mendenhall Syndrome J. Clin. Endocrinol. Metab. 89 2004 1548 1554
37. H. Okamoto, J. Nakae, T. Kitamura, B.-C. Park, I. Dragatsis, and D. Accili Transgenic rescue of insulin receptor-deficient mice J. Clin. Invest. 114 2004 214 223